Ulteriori informazioni
On the occasion of the 80th birthday of Dr. Dr. Herbert Falk an international symposium was held in Freiburg, Germany, on 16-17 October 2004. The aim of the meeting was to look back, to assess progress made and to look forward speculating on the development of the field of gastroenterology and hepatology.
The symposium was divided into four parts: oesophagus and stomach, liver, pancreaticobiliary tract, and small/large bowel. Internationally renowned speakers contributed to the symposium, many of them also contributed to this book. The organizers of the symposium hope that this volume will maintain the memory of a remarkable meeting in honour of an even more remarkable person.
Sommario
Contents.-List of principal contributors.-Preface.-SECTION I: ESOPHAGUS: Treatment of uncomplicated reflux disease.-Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer).-Selective COX-2 inhibitors - safety and side-effects.-SECTION II: STOMACH: The pathogenesis of peptic ulcer and distal gastric cancer.-Vaccination against Helicobacter pylori.-MALT lymphoma: lessons from Germany.-Who gets gastric cancer -predisposition or bad luck.-Upper gastrointestinal tract endoscopy: quo vadis?.-SECTION III: LIVER I: Portal hypertension: diagnosis and treatment.-Current therapy of hepatitis C.-The role of mutation in drug resistance and pathogenesis of hepatitis B and hepatitis C.-SECTION IV: LIVER II: Etiology, pathogenesis and treatment of hemochromatosis.-Wilson disease: from gene to patient.-Hepatic stem cells and hepatocyte transplantation: future therapeutic applications.-SECTION V: BILIARY TRACT: Pathomechanisms of cholestasis: targets for medical treatment.-Adaptive regulation of bile salt transporters in cholestasis.-Treatment of primary biliary cirrhosis: current standards.-Primary sclerosing cholangitis: neoplastic potential and chemopreventive effect of ursodeoxycholic acid.-The pruritus of cholestasis.-SECTION VI: PANCREAS: Stages and course of chronic pancreatitis.-Basis and future of enzyme replacement therapy.-Hedgehog signalling in pancreatic cancer.-SECTION VII: INTESTINAL DISORDERS I: Does JC virus initiate chromosomal instability in colorectal cancer?.-Testing the gut and its function - faecal samples - breath tests and more?.-SECTION VIII: INTESTINAL DISORDERS II: Regulatory T cells in animal models: therapeutic potential.-Imaging of the small and large bowel -from ultrasound to virtual endoscopy.-Colorectal carcinoma - primary prevention and screening.-Treatment of IBD: 'early hit' or step wise escalation?.-The clinical impact of mesalazine for research and therapy in inflammatory bowel disease.-Gastroenterology: History of the future.-Index
